I remain bullish on EverQuote, viewing the post-earnings dip as a compelling buy opportunity given strong long-term growth catalysts and a healthy balance sheet. EverQuote targets $1 billion in annual
EVER's second-quarter results reflect solid performances across both Automotive insurance and Home and Renters insurance verticals, offset by higher expenses.
EverQuote, Inc. (NASDAQ:EVER ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Jayme Mendal - President, CEO & Director Joseph Sanborn - CFO & Treasurer Conference Call
The headline numbers for EverQuote (EVER) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimat

EverQuote (EVER) Beats Q2 Earnings Estimates

06:47pm, Monday, 04'th Aug 2025
EverQuote (EVER) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.17 per share a year ago.

EverQuote (EVER) Q2 EPS Jumps 129%

04:58pm, Monday, 04'th Aug 2025
EverQuote (EVER) Q2 EPS Jumps 129%
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced financial results for the second quarter ended June 30, 2025
EverQuote delivered record Q1 2025 results, with 83% revenue growth and strong cash flow, driven by a robust auto insurance vertical. The company's proprietary technology and AI-powered Smart Campaign
CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that it will report second quarter financial results after t
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.
Given the prospects of the insurance industry, EVER, HMN, ROOT and HCI have the potential to generate better returns than other players.

Bet on Winning DuPont Analysis & Pick 3 Top Stocks

09:31am, Wednesday, 18'th Jun 2025
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
Add INTU, NVMI, EVER and SEZL to your watchlist as each boasts strong liquidity, growth attributes and operational efficiency.
The mean of analysts' price targets for EverQuote (EVER) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE